EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Antihypertensive Drug Use and COVID‐19 Disease Severity in Hospitalized US Veterans: A Retrospective Cohort Study

Merodean Huntsman, Jessica L Marquez, Gregory J Stoddard, Guo Wei, Aaron J Miller iD, Jayant P Agarwal, Sujee Jeyapalina

The Journal of Clinical Hypertension · 2025

DOI: 10.1111/jch.70021 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift The Journal of Clinical Hypertension, 2025. Verfasst von Merodean Huntsman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Plastic and Reconstructive Surgery, Department of Surgery, University of Utah School of Medicine, Salt Lake City, Utah, USA. Hauptthemen laut MEDLINE: COVID-19, Hypertension, Antihypertensive Agents, Veterans. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gilead Sciences, NCATS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This research investigated associations between hypertensive patients with COVID‐19 who did and did not use specific antihypertensive medications and had incurred hospital ventilation/death in the US Veterans Hospital System. This study included de‐identified medical records of 572 994 hypertensive US veterans who were diagnosed with COVID‐19 and hospitalized between March 1, 2020, and February 28, 2022, with a 60‐day follow‐up period. Mechanical ventilation and/or death within 60 days of COVID‐19 hospitalization served as the outcome variables. On multivariable analysis, CCB use was associated with a 9% increased risk of mechanical ventilation, while ACE inhibitors (HR: 0.90), alpha blockers (HR: 0.92), and CCB (HR: 0.93) users were associated with a significantly decreased risk of death. Additional multivariable analysis on those with and without additional comorbidities, such as chronic kidney disease (CKD), heart failure, and diabetes, revealed that in those with at least one additional comorbidity, CCB uses led to a 9% increased deleterious risk for ventilation. In contrast, the use of ACE inhibitors (HR: 0.86), alpha blockers (HR: 0.92), and CCB (HR: 0.93) demonstrated a moderate protective effect against mortality. Lastly, in hypertensive veterans without any additional comorbidities, there was a lack of significant association between hypertensive medication usage and mechanical ventilation and/or death. In summary, although CCB use was associated with an increased risk of requiring mechanical ventilation, it also demonstrated a protective effect against mortality. At the same time, ACEI, alpha blocker, and CCB usage led to a significantly decreased risk for death within all hypertensive hospitalized COVID‐19 veteran cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HypertensionAntihypertensive AgentsVeteransHumansMaleRetrospective StudiesFemaleAgedUnited StatesMiddle AgedHospitalizationRespiration, ArtificialSeverity of Illness IndexComorbiditySARS-CoV-2Angiotensin-Converting Enzyme InhibitorsRisk Factors

Stichwörter der Autor:innen

COVID‐19VA COVID‐19 shared resourcesantihypertensive medicationsdiureticsveterans

Substanzen

Antihypertensive AgentsAngiotensin-Converting Enzyme Inhibitors

Autor:innen und Institutionen

  • Division of Plastic and Reconstructive Surgery, Department of Surgery, University of Utah School of Medicine, Salt Lake City, Utah, USA.
  • George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, Utah, USA.
  • Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA.

ORCID-Profile: Aaron J Miller

Förderung

  • Gilead Sciences
  • NCATS NIH HHS
  • NIH HHS
  • National Center for Advancing Translational Sciences
  • National Institutes of Health

Zitieren

APA

Huntsman, M., Marquez, J. L., Stoddard, G. J., Wei, G., Miller, A. J., Agarwal, J. P., & Jeyapalina, S. (2025). Antihypertensive Drug Use and COVID‐19 Disease Severity in Hospitalized US Veterans: A Retrospective Cohort Study. The Journal of Clinical Hypertension. https://doi.org/10.1111/jch.70021

Vancouver

Huntsman M, Marquez JL, Stoddard GJ, Wei G, Miller AJ, Agarwal JP, et al. Antihypertensive Drug Use and COVID‐19 Disease Severity in Hospitalized US Veterans: A Retrospective Cohort Study. The Journal of Clinical Hypertension. 2025. doi:10.1111/jch.70021

BibTeX
@article{Huntsman2025,
  author = {Huntsman, Merodean and Marquez, Jessica L and Stoddard, Gregory J and Wei, Guo and Miller, Aaron J and Agarwal, Jayant P and Jeyapalina, Sujee},
  title = {Antihypertensive Drug Use and COVID‐19 Disease Severity in Hospitalized US Veterans: A Retrospective Cohort Study},
  journal = {The Journal of Clinical Hypertension},
  year = {2025},
  doi = {10.1111/jch.70021}
}
Kostenlos starten →